-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Gilead Sciences, Lowers Price Target to $145

Benzinga·07/29/2026 12:03:37
Listen to the news
Barclays analyst Emily Field maintains Gilead Sciences (NASDAQ:GILD) with a Equal-Weight and lowers the price target from $155 to $145.